Skip to content
healthcare.dev
Get a free key

VIDAZA

NDC 59572-102, azacitidine, injection, powder, lyophilized, for solution, from Celgene Corporation.

Product NDC
59572-102
Status
Listed
Labeler
Celgene Corporation
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA050794
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59572-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AZACITIDINE100 mg/1

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
59572-102-01595720102011 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (59572-102-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3495a71a-cc04-4776-851f-f185956f32af

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=59572-102

Use it

Look up 59572-102 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59572-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59572-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.